Prescription drug · UNAPPROVED DRUG OTHER
Hyoscyamine Sulfate TAB (hyoscyamine sulfate) NDC 42192-340
Hyoscyamine sulfate .125 mg/1 · Tablet · Oral · Acella Pharmaceuticals, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42192-340-01 | 42192034001 | 100 TABLET in 1 BOTTLE (42192-340-01)Marketed from May 19, 2011 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Hyoscyamine Sulfate TAB
- Generic name (nonproprietary)
- hyoscyamine sulfate
- Active ingredients
- Hyoscyamine sulfate — .125 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Acella Pharmaceuticals, LLC
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 42192-340_40334131-5c80-1b60-e063-6394a90ae21fSPL ID 40334131-5c80-1b60-e063-6394a90ae21fSPL set ID 49fe1783-ab0c-4adb-869b-384121cf7f05RxCUI 1047905UNII F2R8V82B84UPC 0342192340015
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442192034001followed by a unit qualifier and the quantityPackage 42192-0340-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE This product may be used in functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries and diverticulitis. It can also be used to control gastric secretion, visceral spasm and hypermotility in cystitis, pylorospasm and associated abdominal cramps. Along with appropriate analgesics, this product is indicated in symptomatic relief of biliary and renal colic and as a drying agent in the relief of symptoms of acute rhinitis. This product is effective as adjunctive therapy in the treatment of peptic ulcer and irritable bowel syndrome, acute enterocolitis and other functional gastrointestinal disorders.
Excerpt only. Read the full label for complete information.